Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchnanobodyadconcologychina

Review surveys nanobody-drug conjugates in cancer treatment

Chinese immunology journal assesses research progress and current application status of the NDC modality.

PR
By Priya Raman · Science Reporter
Aug 31 20:00 ETSource: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

The wire

  1. 01A review summarizes progress and application status of nanobody-drug conjugates in oncology.
  2. 02Nanobody conjugates are an emerging alternative to conventional antibody-drug conjugates.
  3. 03Review offers no new clinical data.

From the source

[Research progress and application status of nanobody-drug conjugate(NDC) in cancer treatment]

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology · 2026 Sep · Xian G, Li Y, Hu M et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42750332/